Document is current
Any future updates will be listed below
-
Authors
,
Robba, Chiara
Ball, Lorenzo
Battaglini, Denise
Cardim, Danilo
Moncalvo, Emanuela
Brunetti, Iole
Bassetti, Matteo
Giacobbe, Daniele R.
Vena, Antonio
Patroniti, Nicolò
Rocco, Patricia R. M.
Matta, Basil F.
Pelosi, Paolo
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 5 March 2021
First Online: 19 March 2021
Declarations
:
: The study protocol was approved by the ethics review board (Comitato Etico Regione Liguria, protocol n. CER Liguria: 23/2020).
: Local ethical approval was obtained, and consent form was obtained from next of kin, as patients were unconscious at the time of inclusion.
: Dr. Bassetti reports personal fees and other from Angelini, personal fees and other from AstraZeneca, other from Bayer, personal fees and other from Cubist, personal fees and other from Pfizer, personal fees and other from Menarini, personal fees and other from MSD, other from Nabriva, other from Paratek, other from Roche, other from Shionogi, other from Tetraphase, other from The Medicine Company, personal fees and other from Astellas Pharma Inc., personal fees from Gilead Sciences, personal fees from Teva, personal fees from Novartis, grants from Ranbaxy, personal fees from Correvio, personal fees from Molteni, personal fees from Thermo Fisher, outside the submitted work. Dr. Giacobbe reports personal fees from Stepstone Pharma GmbH, personal fees from MSD Italia, personal fees from Correvio Italia, outside the submitted work. Dr. Matta reports personal fees from Masimo.
